Hormonal therapies and venous thrombosis: considerations for prevention and management-a reappraisal

Res Pract Thromb Haemost. 2023 Apr 15;7(4):100155. doi: 10.1016/j.rpth.2023.100155. eCollection 2023 May.

Jonathan Douxfils^{1

2}, Laure Morimont^{1

2}, Mitchell D Creinin³, Ulysse Gaspard⁴, Jean-Michel Foidart^{5

6}

¹ Qualiblood sa, Namur, Belgium.
² Department of Pharmacy, Faculty of Medicine, University of Namur, Namur Research Institute for Life Sciences, Clinical Pharmacology Research Group, Namur, Belgium.
³ Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, California, USA.
⁴ Department of Obstetrics and Gynecology, University of Liège, Belgium.
⁵ Estetra SRL, An affiliate Company of Mithra Pharmaceuticals, Liège, Belgium.
⁶ University of Liège, Liège, Belgium.

No abstract available